Northern Trust’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.9K | Sell |
14,373
-800
| -5% | -$1.27K | ﹤0.01% | 4324 |
|
|
2025
Q1 | $22.6K | Buy |
15,173
+2,400
| +19% | +$3.58K | ﹤0.01% | 4330 |
|
|
2024
Q4 | $51.1K | Sell |
12,773
-1
| -0% | -$4 | ﹤0.01% | 4251 |
|
|
2024
Q3 | $160K | Sell |
12,774
-29,428
| -70% | -$368K | ﹤0.01% | 3947 |
|
|
2024
Q2 | $616K | Sell |
42,202
-2,610
| -6% | -$38.1K | ﹤0.01% | 3428 |
|
|
2024
Q1 | $1.01M | Buy |
44,812
+3,007
| +7% | +$67.5K | ﹤0.01% | 3305 |
|
|
2023
Q4 | $791K | Sell |
41,805
-366
| -0.9% | -$6.92K | ﹤0.01% | 3392 |
|
|
2023
Q3 | $722K | Buy |
42,171
+1,025
| +2% | +$17.5K | ﹤0.01% | 3397 |
|
|
2023
Q2 | $1.23M | Buy |
41,146
+31,336
| +319% | +$940K | ﹤0.01% | 3273 |
|
|
2023
Q1 | $287K | Buy |
9,810
+281
| +3% | +$8.22K | ﹤0.01% | 3688 |
|
|
2022
Q4 | $188K | Hold |
9,529
| – | – | ﹤0.01% | 3895 |
|
|
2022
Q3 | $289K | Sell |
9,529
-19
| -0.2% | -$576 | ﹤0.01% | 3695 |
|
|
2022
Q2 | $220K | Sell |
9,548
-32,989
| -78% | -$760K | ﹤0.01% | 3878 |
|
|
2022
Q1 | $1.9M | Buy |
42,537
+2,542
| +6% | +$114K | ﹤0.01% | 3128 |
|
|
2021
Q4 | $1.54M | Sell |
39,995
-907
| -2% | -$34.9K | ﹤0.01% | 3354 |
|
|
2021
Q3 | $2.08M | Sell |
40,902
-11,038
| -21% | -$560K | ﹤0.01% | 3272 |
|
|
2021
Q2 | $4.52M | Buy |
51,940
+43,050
| +484% | +$3.75M | ﹤0.01% | 2901 |
|
|
2021
Q1 | $396K | Buy |
8,890
+5,809
| +189% | +$259K | ﹤0.01% | 3889 |
|
|
2020
Q4 | $79K | Buy |
3,081
+1,406
| +84% | +$36.1K | ﹤0.01% | 4163 |
|
|
2020
Q3 | $44K | Buy |
1,675
+424
| +34% | +$11.1K | ﹤0.01% | 4120 |
|
|
2020
Q2 | $35K | Buy |
1,251
+573
| +85% | +$16K | ﹤0.01% | 4099 |
|
|
2020
Q1 | $10K | Buy |
+678
| New | +$10K | ﹤0.01% | 4148 |
|